SCHEMBL24384147

SCHEMBL24384147

C#Cc1ccc(OC)c(N(CC)CCCS(=O)(=O)OCC(F)(F)F)c1

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26886001 0.89 HCRTR2 (0.32) ALDH1A1L3MBTL1KDM4E
SCHEMBL24384238 0.88 KMT2A (0.31)
SCHEMBL24383973 0.87 GABRG2 (0.34)
SCHEMBL24384166 0.85 ALDH1A1 (0.33) ALDH1A1L3MBTL1KDM4E
SCHEMBL24384148 0.82 ALDH1A1 (0.35) ALDH1A1L3MBTL1KDM4E
SCHEMBL24384205 0.80 ALDH1A1 (0.30) ALDH1A1L3MBTL1
SCHEMBL24383990 0.76
SCHEMBL24394327 0.75 GABRG2 (0.35)
SCHEMBL24384014 0.75 ALDH1A1 (0.43) ALDH1A1L3MBTL1
SCHEMBL24384200 0.72 SIGMAR1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382928-A1 EUROPIUM(III) COMPLEXES AS PH SENSORS CISBIO BIOASSAYS (FR) 2023-11-30 US disclosed
WO-2022090284-A1 EUROPIUM(III) COMPLEXES AS PH SENSORS CISBIO BIOASSAYS (FR) 2022-05-05 WO disclosed
EP-3992182-A1 EUROPIUM(III) COMPLEXES AS PH SENSORS Cisbio Bioassays (FR) 2022-05-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382928-A1 EUROPIUM(III) COMPLEXES AS PH SENSORS NCS1, GALR3, TAS1R3 ALDH1A1 3455/4885L3MBTL1 2915/4885KDM4E 3023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.